Gene · 3783
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Catecholamine induces endothelial dysfunction via Angiotensin II and intermediate conductance calcium activated potassium channel. | Biomed Pharmacother | 2024 | 38889637 | PubTator, text mining | PubMed |
| Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. | World J Gastroenterol | 2024 | 38817665 | PubTator, text mining | PubMed |
| The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies. | Acta Pharm Sin B | 2024 | 38799637 | PubTator, text mining | PubMed |
| Regulation of T Lymphocyte Functions through Calcium Signaling Modulation by Nootkatone. | Int J Mol Sci | 2024 | 38791278 | PubTator, text mining | PubMed |
| TBX3 transfection and nodal signal pathway inhibition promote differentiation of adipose mesenchymal stem cell to cardiac pacemaker-like cells. | Stem Cell Res Ther | 2024 | 38778426 | PubTator, text mining | PubMed |
| Investigating the Impact of Electrostatic Interactions on Calmodulin Binding and Ca2+-Dependent Activation of the Calcium-Gated Potassium SK4 Channel. | Int J Mol Sci | 2024 | 38673845 | PubTator, text mining | PubMed |
| Unveiling the link between lactate metabolism and rheumatoid arthritis through integration of bioinformatics and machine learning. | Sci Rep | 2024 | 38644410 | PubTator, text mining | PubMed |
| Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31. | Front Pharmacol | 2024 | 38638868 | PubTator, text mining | PubMed |
| Identification of Riluzole derivatives as novel calmodulin inhibitors with neuroprotective activity by a joint synthesis, biosensor, and computational guided strategy. | Biomed Pharmacother | 2024 | 38636396 | PubTator, text mining | PubMed |
| Kca3.1-Related Cellular Signalling Involved in Cancer Proliferation. | Cell Physiol Biochem | 2024 | 38623063 | PubTator, text mining | PubMed |
| Elevated interleukin-8 expression by skin fibroblasts as a potential contributor to pain in women with Fabry disease. | PLoS One | 2024 | 38593151 | PubTator, text mining | PubMed |
| Expression of KCNN4 in adult-type diffuse gliomas and its correlations with clinicopathological features and patient prognosis. | Transl Oncol | 2024 | 38555740 | PubTator, text mining | PubMed |
| Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I TTR carriers in the general population. | Amyloid | 2024 | 38445629 | PubTator, text mining | PubMed |
| Activity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer? | Int J Mol Sci | 2024 | 38396628 | PubTator, text mining | PubMed |
| Retinal Cell Biology in Health and Disease. | Cells | 2024 | 38391910 | PubTator, text mining | PubMed |
| The Gárdos Channel and Piezo1 Revisited: Comparison between Reticulocytes and Mature Red Blood Cells. | Int J Mol Sci | 2024 | 38338693 | PubTator, text mining | PubMed |
| M2 macrophage‑derived exosomes alleviate KCa3.1 channel expression in rapidly paced HL‑1 myocytes via the NF‑κB (p65)/STAT3 signaling pathway. | Mol Med Rep | 2024 | 38334149 | PubTator, text mining | PubMed |
| Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens. | Genome Biol | 2024 | 38308274 | PubTator, text mining | PubMed |
| An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects. | Molecules | 2024 | 38257386 | PubTator, text mining | PubMed |
| Enhancing Human Cutaneous Wound Healing through Targeted Suppression of Large Conductance Ca2+-Activated K+ Channels. | Int J Mol Sci | 2024 | 38255877 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3783/papers?page=8